Are you Dr. Belanoff?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 39 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-498-5710- Is this information wrong?
Summary
- Dr. Joseph Belanoff, MD is a board certified psychiatrist in Stanford, California. He is currently licensed to practice medicine in California.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1992 - 1996
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1992
Certifications & Licensure
- CA State Medical License 1993 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Age-Related Changes in Stress Hormone Regulation Start of enrollment: 2000 Dec 01
Publications & Presentations
PubMed
- 1 citationsBiochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With HypercortisolismJohn C. Parker, Andreas G. Moraitis, Joseph K. Belanoff> ;AACE Clinical Case Reports. 2021 Jul 12
- 13 citationsInsights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative DiseasesAlejandro F. De Nicola, Maria Meyer, Rachida Guennoun, Michael Schumacher, Hazel Hunt, Joseph K. Belanoff, E. Ronald de Kloet, Maria Claudia Gonzalez Deniselle> ;International Journal of Molecular Sciences. 2020 Mar 20
- 14 citationsLong-term effects of the glucocorticoid receptor modulator CORT113176 in murine motoneuron degeneration.Maria Meyer, Maria Sol Kruse, Laura Garay, Analia Lima, Paulina Roig, Hazel Hunt, Joseph K. Belanoff, E. Ronald de Kloet, Maria Claudia Gonzalez Deniselle, Alejandro F...> ;Brain Research. 2020 Jan 15
- Join now to see all
Press Mentions
- Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2022 Earnings Call TranscriptMarch 3rd, 2023
- William Guyer to Join Corcept as Chief Development OfficerAugust 12th, 2021
- Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications OfficerJuly 12th, 2021
- Join now to see all
Professional Memberships
- Member